Stem Cell Source and Outcome After Hematopoietic Stem Cell Transplantation (HSCT) in Children and Adolescents with Acute Leukemia

Pediatric Clinics of North America

Volumn 57, Issue 1, 2010, Pages 27-46

  Peters, Christina ^a   Cornish, Jacqueline M ^b   Parikh, Suhag H ^c   Kurtzberg, Joanne ^c  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute Leukemia; Adolescents; Allogeneic stem cell transplantation; Bone marrow; Children; Peripheral blood stem cells; Umbilical Cord blood

Indexed keywords

ADOLESCENT; CHILD; CYTOLOGY; DONOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; METHODOLOGY; REVIEW; STEM CELL; TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; STEM CELLS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 77951627548     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2010.01.004     Document Type: Review

References (117)

1. Jacobson, L., Marks, E., Robson, M., et al. Effect of spleen protection on mortality following X-irradiation. J Lab Clin Med 34 (1949), 1538–1543.
2. Lorenz, E., Uphoff, D., Reid, T., et al. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 12 (1951), 197–201.
3. Dausset, J., Iso-leuco-anticorps. Acta Haematologica 20 (1958), 156–166.
4. Van Rood, J., Eernisse, J., Van Leeuwen, A., Leucocyte antibodies in sera from pregnant women. Nature 181 (1958), 1735–1736.
5. De Koning, J., Van Bekkum, D.W., Dicke, K.A., et al. Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency. Lancet 1:7608 (1969), 1223–1227.
6. Gatti, R.A., Meuwissen, H.J., Allen, H.D., et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2:7583 (1968), 1366–1369.
7. Thomas, E.D., Buckner, C.D., Banaji, M., et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49:4 (1977), 511–533.
8. Hansen, J., Clift, R., Thomas, E., et al. Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 303:10 (1979), 565–567.
9. McCullough, J., Perkins, H.A., Hansen, J., The national marrow donor program with emphasis on the early years. Transfusion 46:7 (2006), 1248–1255.
10. Goodman, J.W., Hodgson, G.S., Evidence for stem cells in the peripheral blood of mice. Blood 19:6 (1962), 702–714.
11. Gratwohl, A., Baldomero, H., Schwendener, A., et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 43:4 (2009), 275–291.
12. Aversa, F., Tabilio, A., Velardi, A., et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339:17 (1998), 1186–1193.
13. Broxmeyer, H.E., Douglas, G.W., Hangoc, G., et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 86:10 (1989), 3828–3832.
14. Gluckman, E., Broxmeyer, H., Auerbach, A., et al. Hematopoietic reconstitution in a patient with Fanconi's Anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:17 (1989), 1174–1178.
15. Wagner, J., Kernan, N., Steinbuch, M., et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 346:8969 (1995), 214–219.
16. Rubinstein, P., Dobrila, L., Rosenfield, R.E., et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 92:22 (1995), 10119–10122.
17. Kurtzberg, J., Laughlin, M., Graham, M.L., et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335:3 (1996), 157–166.
18. Rubinstein, P., Carrier, C., Scaradavou, A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339:22 (1998), 1565–1577.
19. Gluckman, E., Rocha, V., Boyer-Chammard, A., et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 337:6 (1997), 373–381.
20. Rocha, V., Cornish, J., Sievers, E.L., et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97:10 (2001), 2962–2971.
21. Barker, J.N., Davies, S.M., DeFor, T., et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 97:10 (2001), 2957–2961.
22. Fraser, J., Cairo, M., Wagner, E., et al. Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother 7:6 (1998), 521–561.
23. Kurtzberg, J., Wall, D.A., Wagner, J.E., et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of 193 unrelated donor umbilical cord blood transplantations in pediatric patients with malignant conditions. Biol Blood Marrow Transplant, 11(2), 2005, 2 [abstract: 6].
24. Kurtzberg, J., Prasad, V.K., Carter, S.L., et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 112:10 (2008), 4318–4327.
25. Rowley, J., Backtracking leukemia to birth. Nat Med 4:2 (1998), 150–151.
26. Peters, C., Ladenstein, R., Ochsenreiter, W., et al. Survey of supportive care standards for paediatric allogeneic stem cell transplantation patients in Europe: a first report from the EBMT Paediatric Diseases Working Party. Bone Marrow Transplant 18:Suppl 2 (1996), 17–24.
27. Buckner, C.D., Clift, R.A., Sanders, J.E., et al. Marrow harvesting from normal donors. Blood 64:3 (1984), 630–634.
28. Kletzel, M., Olszewski, M., Danner-Koptik, K., et al. Red cell salvage and reinfusion in pediatric bone marrow donors. Bone Marrow Transplant 24:4 (1999), 385–388.
29. Martinez, A.M., Sastre, A., Munoz, A., et al. Recombinant human erythropoietin (rh-Epo) administration to normal child bone marrow donors. Bone Marrow Transplant 22:2 (1998), 137–138.
30. Sanders, J., Buckner, C.D., Bensinger, W.I., et al. Experience with marrow harvesting from donors less than two years of age. Bone Marrow Transplant 2:1 (1987), 45–50.
31. Halter, J., Kodera, Y., Ispizua, A.U., et al. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 94:1 (2009), 94–101.
32. Vamvakas, E.C., Blajchman, M.A., Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 113:15 (2009), 3406–3417.
33. Traineau, R., Elghouzzi, M.H., Bierling, P., (Trans.) [Update on infectious risks associated with blood products] Rev Prat 59:1 (2009), 86–89 [in French].
34. Wiener, L.S., Steffen-Smith, E., Fry, T., et al. Hematopoietic stem cell donation in children: a review of the sibling donor experience. J Psychosoc Oncol 25:1 (2007), 45–66.
35. Delany, L., Month, S., Savulescu, J., et al. Altruism by proxy: volunteering children for bone marrow donation. Br Med J 312:7025 (1996), 240–243.
36. Pentz, R.D., Haight, A.E., Noll, R.B., et al. The ethical justification for minor sibling bone marrow donation: a Case Study. Oncologist 13:2 (2008), 148–151.
37. Horowitz, M.M., Confer, D.L., Evaluation of hematopoietic stem cell donors. Hematology Am Soc Hematol Educ Program, 2005, 469–475.
38. Grupp, S.A., Cohn, S.L., Wall, D., et al. Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy day. Pediatr Blood Cancer 46:7 (2006), 719–722.
39. Lipton, J.M., Peripheral blood as a stem cell source for hematopoietic cell transplantation in children: is the effort in vein?. Pediatr Transplant 7:Suppl 3 (2003), 65–70.
40. Pulsipher, M.A., Chitphakdithai, P., Logan, B.R., et al. Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood 114:13 (2009), 2606–2616.
41. Sevilla, J., Gonzalez-Vicent, M., Madero, L., et al. Large volume leukapheresis in small children: safety profile and variables affecting peripheral blood progenitor cell collection. Bone Marrow Transplant 31:4 (2003), 263–267.
42. Bortin, M.M., D'Amaro, J., Bach, F.H., et al. HLA associations with leukemia. Blood 70:1 (1987), 227–232.
43. Calin, G.A., Trapasso, F., Shimizu, M., et al. Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 352:16 (2005), 1667–1676.
44. Goldin, L.R., Pfeiffer, R.M., Li, X., et al. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood 104:6 (2004), 1850–1854.
45. Ripert, M., Menegaux, F., Perel, Y., et al. Familial history of cancer and childhood acute leukemia: a French population-based case-control study. Eur J Cancer Prev 16:5 (2007), 466–470.
46. Bennett, C.L., Evens, A.M., Andritsos, L.A., et al. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol 135:5 (2006), 642–650.
47. Hsia, C.C., Linenberger, M., Howson-Jan, K., et al. Acute myeloid leukemia in a healthy hematopoietic stem cell donor following past exposure to a short course of G-CSF. Bone Marrow Transplant 42:6 (2008), 431–432.
48. Makita, K., Ohta, K., Mugitani, A., et al. Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest. Bone Marrow Transplant 33:6 (2004), 661–665.
49. Pulsipher, M.A., Chitphakdithai, P., Miller, J.P., et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood 113:15 (2009), 3604–3611.
50. Pulsipher, M.A., Levine, J.E., Hayashi, R.J., et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the Pediatric Blood and Marrow Transplant Consortium Experience (PBMTC) 1996–2003. Bone Marrow Transplant 35:4 (2004), 361–367.
51. Pulsipher, M.A., Nagler, A., Iannone, R., et al. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer 46:4 (2006), 422–433.
52. Diaz, M.A., Vicent, M.G., Gonzalez, M.E., et al. Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients. Bone Marrow Transplant 34:5 (2004), 433–438.
53. Levine, J.E., Wiley, J., Kletzel, M., et al. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD. Bone Marrow Transplant 25:1 (2000), 13–18.
54. Watanabe, T., Takaue, Y., Kawano, Y., et al. HLA-identical sibling peripheral blood stem cell transplantation in children and adolescents. Biol Blood Marrow Transplant 8:1 (2002), 26–31.
55. Eapen, M., Horowitz, M.M., Klein, J.P., et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the histocompatibility and alternate stem cell source working committee of the international bone marrow transplant registry. J Clin Oncol 22:24 (2004), 4872–4880.
56. Frangoul, H., Nemecek, E.R., Billheimer, D., et al. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood 110:13 (2007), 4584–4587.
57. Committee on Obstetric Practice, Committee on Genetics, ACOG committee opinion number 399, February 2008: umbilical cord blood banking. Obstet Gynecol 111:2 Pt 1 (2008), 475–477.
58. Ballen, K.K., Barker, J.N., Stewart, S.K., et al. Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant 14:3 (2008), 356–363.
59. Kurtzberg, J., Lyerly, A.D., Sugarman, J., Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. J Clin Invest 115:10 (2005), 2592–2597.
60. Lubin, B.H., Shearer, W.T., Cord blood banking for potential future transplantation. Pediatrics 119:1 (2007), 165–170.
61. Arico, M., Valsecchi, M.G., Camitta, B., et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 342:14 (2000), 998–1006.
62. Balduzzi, A., Valsecchi, M.G., Uderzo, C., et al. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet 366:9486 (2005), 635–642.
63. Schrauder, A., Reiter, A., Gadner, H., et al. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. J Clin Oncol 24:36 (2006), 5742–5749.
64. Wheeler, K.A., Richards, S.M., Bailey, C.C., et al. Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI. Blood 96:7 (2000), 2412–2418.
65. Wheeler, K., Richards, S., Bailey, C., et al. Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical research council working party on childhood leukaemia. Br J Haematol 101:1 (1998), 94–103.
66. Eapen, M., Raetz, E., Zhang, M.-J., et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the center for international blood and marrow transplant research. Blood 107:12 (2006), 4961–4967.
67. Gaynon, P.S., Harris, R.E., Altman, A.J., et al. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: children's Oncology Group Study CCG-1941. J Clin Oncol 24:19 (2006), 3150–3156.
68. Woods, W.G., Neudorf, S., Gold, S., et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group. Blood 97:1 (2001), 56–62.
69. Bleakley, M., Lau, L., Shaw, P.J., et al. Bone marrow transplantation for paediatric AML in first remission: a systematic review and meta-analysis. Bone Marrow Transplant 29:10 (2002), 843–852.
70. Horan, J.T., Alonzo, T.A., Lyman, G.H., et al. Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group. J Clin Oncol 26:35 (2008), 5797–5801.
71. Messerer, D., Engel, J., Hasford, J., et al. Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica 93:6 (2008), 826–833.
72. Aladjidi, N., Auvrignon, A., Leblanc, T., et al. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French leucemie aique myeloide enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology. J Clin Oncol 21:23 (2003), 4377–4385.
73. Meisel, R., Enczmann, J., Balzer, S., et al. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Klin Padiatr 217:3 (2005), 135–141.
74. Smythe, J., Armitage, S., McDonald, D., et al. Directed sibling cord blood banking for transplantation: the 10-year experience in the national blood service in England. Stem Cells 25:8 (2007), 2087–2093.
75. Rocha, V., Wagner, J.E., Sobocinski, K.A., et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 342:25 (2000), 1846–1854.
76. Rocha, V., Locatelli, F., Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 41:2 (2008), 207–214.
77. Cornish, J., Unrelated donor transplant for acute leukaemia in children–the UK experience. Pathol Biol (Paris) 53:3 (2005), 167–170.
78. Green, A., Clarke, E., Hunt, L., et al. Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome. Blood 94:7 (1999), 2236–2246.
79. Marks, D.I., Bird, J.M., Vettenranta, K., et al. T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemia. Biol Blood Marrow Transplant 6:6 (2000), 646–653.
80. Oakhill, A., Pamphilon, D.H., Potter, M.N., et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 94:3 (1996), 574–578.
81. Vettenranta, K., Saarinen-Pihkala, U.M., Cornish, J., et al. Pediatric marrow transplantation for acute leukemia using unrelated donors and T-replete or -depleted grafts: a case-matched analysis. Bone Marrow Transplant 25:4 (2000), 395–399.
82. Dini, G., Cancedda, R., Locatelli, F., et al. Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO). Haematologica 86:5 (2001), 451–456.
83. Dini, G., Valsecchi, M.G., Micalizzi, C., et al. Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission. Bone Marrow Transplant 32:3 (2003), 325–331.
84. Eapen, M., Rubinstein, P., Zhang, M.J., et al. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. J Clin Oncol 24:1 (2006), 145–151.
85. Garderet, L., Labopin, M., Gorin, N.C., et al. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow. Bone Marrow Transplant 31:1 (2003), 23–29.
86. Cornish, J.M., Pamphilon, D.H., Potter, M.N., et al. Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion. Bone Marrow Transplant 18:Suppl 2 (1996), 31–35.
87. Oakhill, A., Pamphilon, D.H., Potter, M.N., et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 93:3 (1996), 674–676.
88. Locatelli, F., Zecca, M., Messina, C., et al. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia 16:11 (2002), 2228–2237.
89. Schrauder, A., Stackelberg, A., Bader, P., et al. Reduction of treatment related mortality after stem cell transplantation in children and adolescents with ALL undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 15(2), 2009, 80.
90. Kollman, C., Howe, C.W., Anasetti, C., et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 98:7 (2001), 2043–2051.
91. MacMillan, M.L., Davies, S.M., Nelson, G.O., et al. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 14:Suppl 9 (2008), 16–22.
92. Meisel, R., Laws, H.J., Balzer, S., et al. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies. Biol Blood Marrow Transplant 13:11 (2007), 1338–1345.
93. Michel, G., Rocha, V., Chevret, S., et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 102:13 (2003), 4290–4297.
94. Eapen, M., Rubinstein, P., Zhang, M.J., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 369:9577 (2007), 1947–1954.
95. Dalle, J.H., Duval, M., Moghrabi, A., et al. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 33:6 (2004), 605–611.
96. Hough, R.L.M., Michel, G., Locatelli, F., et al. Outcomes of fully haplo-identical haematopoietic stem cell transplantation compared to unrelated cord blood transplantation in children with acute lymphoblastic leukaemia. A retrospective analysis on behalf of Eurocord, PDWP and ALWP of EBMT. Bone Marrow Transplant 39 (2007), S1–S3.
97. Barker, J.N., Weisdorf, D.J., DeFor, T.E., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105:3 (2005), 1343–1347.
98. Fernández, M.N., Regidor, C., Cabrera, R., et al. Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highlypurified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 31:6 (2003), 535–544.
99. Gonzalo-Daganzo, R., Regidor, C., Martin-Donaire, T., et al. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 11:3 (2009), 278–288.
100. Kelly, S.S., Sola, C.B.S., de Lima, M., et al. Ex vivo expansion of cord blood. Bone Marrow Transplant 44:10 (2009), 673–681.
101. Hwang, W.Y., Samuel, M., Tan, D., et al. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant 13:4 (2007), 444–453.
102. Ruggeri, L., Capanni, M., Urbani, E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:5562 (2002), 2097–2100.
103. Handgretinger, R., Lang, P., The history and future prospective of haplo-identical stem cell transplantation. Cytotherapy 10:5 (2008), 443–451.
104. Lang, P., Schumm, M., Greil, J., et al. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. Klin Padiatr 217:6 (2005), 334–338.
105. Marks, D.I., Khattry, N., Cummins, M., et al. Haploidentical stem cell transplantation for children with acute leukaemia. Br J Haematol 134:2 (2006), 196–201.
106. Peters, C., Another step forward towards improved outcome after HLA-haploidentical stem cell transplantation. Leukemia 18:11 (2004), 1769–1771.
107. Klingebiel, T., Handgretinger, R., Lang, P., et al. Haploidentical transplantation for acute lymphoblastic leukemia in childhood. Blood Rev 18:3 (2004), 181–192.
108. Lang, P., Greil, J., Bader, P., et al. Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells Mol Dis 33:3 (2004), 281–287.
109. Klingebiel, T., Cornish, J., Labopin, M., et al. Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplant in children with very-high risk acute lymphoblastic leukemia - impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group. Blood, 2009 doi:10.1182/blood-2009-03-207001 [Epub ahead of Print].
110. Ball, L.M., Lankester, A.C., Bredius, R.G., et al. Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation. Bone Marrow Transplant 35:Suppl 1 (2005), S35–S38.
111. Perruccio, K., Tosti, A., Burchielli, E., et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 106:13 (2005), 4397–4406.
112. Velardi, A., Ruggeri, L., Capanni, M., et al. Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. Hematol J 5:Suppl 3 (2004), S87–S90.
113. Feuchtinger, T., Richard, C., Pfeiffer, M., et al. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. Klin Padiatr 217:6 (2005), 339–344.
114. Handgretinger, R., Chen, X., Pfeiffer, M., et al. Cellular immune reconstitution after haploidentical transplantation in children. Biol Blood Marrow Transplant 14:1 Suppl 1 (2008), 59–65.
115. Montagna, D., Maccario, R., Locatelli, F., Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic stem cell transplantation. Int J Immunogenet 35:4–5 (2008), 389–393.
116. Locatelli, F., Comoli, P., Montagna, D., et al. Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 17:3 (2004), 479–492.
117. Comoli, P., Maccario, R., Locatelli, F., et al. Adoptive transfer of herpesvirusspecific cytotoxic T lymphocytes in transplant recipients. Herpes 7:1 (2000), 9–12.